Related Experiment Video
Updated: Jul 17, 2025

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
Published on: October 20, 2023
Transcriptional Targets of TWIST1 in Human Mesenchymal Stem/Stromal Cells Mechanistically Link Stem/Progenitor and
Christopher L Haga1, Cori N Booker1, Ana Carvalho1
1The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Department of Molecular Medicine, Jupiter, FL, USA.
Abstract:
Despite extensive clinical testing, mesenchymal stem/stromal cell (MSC)-based therapies continue to underperform with respect to efficacy, which reflects the paucity of biomarkers that predict potency prior to patient administration. Previously, we reported that TWIST1 predicts inter-donor differences in MSC quality attributes that confer potency. To define the full spectrum of TWIST1 activity in MSCs, the present work employed integrated omics-based profiling to identify a high-confidence set of TWIST1 targets, which mapped to cellular processes related to ECM structure/organization, skeletal and circulatory system development, interferon gamma signaling, and inflammation. These targets are implicated in contributing to both stem/progenitor and paracrine activities of MSCs indicating these processes are linked mechanistically in a TWIST1-dependent manner. Targets implicated in extracellular matrix dynamics further implicate TWIST1 in modulating cellular responses to niche remodeling. Novel TWIST1-regulated genes identified herein may be prioritized for future mechanistic and functional studies.
Insights
TWIST1 is a key regulator of mesenchymal stem/stromal cell (MSC) potency. Identifying TWIST1 targets reveals its role in MSC function, potentially improving cell therapies.
Area of Science:
- Stem Cell Biology
- Regenerative Medicine
- Molecular Biology
Background:
- Mesenchymal stem/stromal cell (MSC) therapies show limited efficacy due to a lack of potency biomarkers.
- Previous research identified TWIST1 as a predictor of MSC quality and potency.
Purpose of the Study:
- To comprehensively define the full range of TWIST1 activity in MSCs.
- To identify novel TWIST1 target genes and associated cellular processes.
Main Methods:
- Integrated omics-based profiling was employed to identify high-confidence TWIST1 targets.
- Bioinformatic analysis mapped identified targets to specific cellular functions and pathways.
Main Results:
- A set of TWIST1 targets was identified, involved in extracellular matrix (ECM) organization, skeletal and circulatory development, and inflammatory signaling.
- These targets link TWIST1 to both stem/progenitor and paracrine functions of MSCs.
- TWIST1's role in modulating cellular responses to niche remodeling via ECM dynamics was highlighted.
Conclusions:
- TWIST1 is a crucial regulator of multiple MSC functions, including stemness, paracrine activity, and response to niche.
- The identified TWIST1 targets provide a basis for future research into MSC potency and therapeutic applications.
- Understanding TWIST1-mediated pathways can lead to improved MSC-based therapies.
More Related Videos
07:05TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
10:48Differentiation of a Human Neural Stem Cell Line on Three Dimensional Cultures, Analysis of MicroRNA and Putative Target Genes
Published on: April 12, 2015
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Niche
Canonical Wnt Signaling Pathway
Somatic to iPS Cell Reprogramming
Lineage Commitment
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...